妊活サプリメント市場- 世界の産業規模、シェア、動向、機会、予測、2018年-2028年成分別、製品別、最終用途別、流通チャネル別、地域別、競合予測・機会

妊活サプリの世界市場規模は2022年に18億7,000万米ドルとなり、2028年までのCAGRは6.29%で、予測期間中に目覚ましい成長を遂げると予測されています。

今後数年間は、喫煙者の増加やアルコール・カフェイン消費の増加に起因する出生率の低下が市場成長を牽引すると予想されます。また、ヘルスケアコストの上昇、ライフスタイルの進化、食品の革新、医療技術の進歩などの要因も、これらの製品に対する需要の高まりに寄与しています。さらに、女性の妊娠の遅れや継続的な出生率の低下により、世界の不妊治療サプリメント市場は拡大しています。興味深いことに、COVID-19のパンデミックは、このウイルスが個人の生殖能力に影響を与える可能性があることが調査で示されたため、妊活サプリの需要に好影響を与えました。さらに、2021年1月に発表された「COVID-19の疾病過程における亜鉛の潜在的役割と生殖への影響の可能性」と題する研究では、亜鉛サプリメントがコロナウイルスに対する身体の免疫反応によって引き起こされる卵子細胞や精子細胞へのダメージを緩和し、免疫力を高める可能性が示唆されました。このような調査結果は、パンデミック時の不妊治療サプリメントの需要増につながり、市場にプラスの影響を与えています。

主な市場促進要因

不妊への懸念の高まり

近年、世界の不妊治療サプリメント市場は、個人やカップルの間で不妊に関する懸念が憂慮すべきほど高まっていることを背景に、大幅な成長を遂げています。ライフスタイルの変化、家族計画の遅れ、ストレスレベルの上昇といった要因が生殖機能に影響を及ぼす中、人々は潜在的な解決策として不妊治療サプリメントに注目するようになっています。不妊治療サプリメント市場の成長を促進する重要な要因の一つは、人口動態の変化です。多くの先進諸国では、出産を遅らせる傾向が顕著です。夫婦は20代後半から30代になるまで家庭を持つのを待つようになっています。この傾向は、キャリアの目標や経済的要因に影響されることが多いが、加齢に伴う不妊の課題も伴う。女性は年齢を重ねるにつれて生殖能力が低下し、妊娠が難しくなります。このような人口動態の変化により、妊娠の可能性を高めたいと考える高齢カップルの間で、不妊治療サプリメントの需要が急増しています。現代のライフスタイルは、ストレスが多く、座りっぱなしの生活、食生活の乱れなどが目立ちます。これらの要因は、生殖の健康に悪影響を及ぼす可能性があります。特にストレスはホルモンバランスを乱し、生殖能力に影響を及ぼすことが知られています。このような生活習慣に関連した不妊の問題に対する認識が高まるにつれ、個人やカップルはこれらの影響を軽減する方法を模索しています。ビタミン、ミネラル、ハーブエキスが配合されていることが多い不妊治療サプリメントは、生殖の健康をサポートするための自然で利用しやすい手段として認識されています。現在、多くのカップルが、様々な個人的、職業的な配慮から、子作りに踏み切るまで長く待つようになっています。しかし、このような遅れは、特に35歳以上の女性にとって、不妊の不安を増大させることにつながります。妊活サプリメントは、妊娠を試みる前に生殖機能を最適化するための事前対策と考えられています。その結果、これらのサプリメントは、多くのカップルにとって家族計画の旅の不可欠な一部となっています。不妊の問題や不妊治療サプリメントの潜在的な効果に対する意識の高まりが、市場の成長に極めて重要な役割を果たしています。不妊の悩みや解決策に関する情報は、インターネットやソーシャルメディアを通じて容易に入手できるようになっています。これは、個人やカップルが生殖の健康を管理し、彼らの特定のニーズに対処するために不妊サプリメントのようなオプションを探索する権限を与えています。eコマースの台頭は、不妊治療サプリメントをより身近で便利なものにしました。消費者はオンラインで様々な製品を調査、比較、注文することができ、店舗や薬局に出向く必要がなくなっています。このアクセスのしやすさが市場の拡大に貢献し、より幅広い消費者層が妊活サプリメントを利用できるようになっています。

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 妊活サプリの世界市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 成分別（天然物、合成物／天然物と合成物のブレンド）
  • 製品別（カプセル、錠剤、ソフトジェル、粉末、液体）
  • 最終用途別（男性、女性）
  • 流通チャネル別（OTC、処方箋）
  • 地域別
  • 企業別（2022年）
• 製品市場マップ
  • 成分別
  • 製品別
  • 最終用途別
  • 流通チャネル別
  • 地域別

第6章 北米妊活サプリ市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 成分別
  • 製品別
  • 最終用途別
  • 流通チャネル別
  • 国別
• 北米国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州妊活サプリ市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 成分別
  • 製品別
  • 最終用途別
  • 流通チャネル別
  • 国別
• 欧州国別分析
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン

第8章 アジア太平洋妊活サプリメント市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 成分別
  • 製品別
  • 最終用途別
  • 流通チャネル別
  • 国別
• アジア太平洋地域国別分析
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国

第9章 南米妊活サプリ市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 成分別
  • 製品別
  • 最終用途別
  • 流通チャネル別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカ妊活サプリ市場の展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 成分別
  • 製品別
  • 最終用途別
  • 流通チャネル別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の展開
• 合併・買収
• 製品発表

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Fairhaven Health LLC
• Coastal Sciences
• LENUS Pharma GesmbH
• Orthomol Pharmazeutische Vertriebs GmbH
• Exeltis USA Inc
• PrepMe LLC
• Bionova Inc
• TTK Healthcare Ltd
• Vitabiotics Ltd
• VH Nutrition LLC

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Fertility Supplements Market has valued at USD 1.87 billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.29% through 2028. The market growth is expected to be driven in the upcoming years by decreasing fertility rates attributed to an increase in smokers and the growing consumption of alcohol and caffeine. Factors such as elevated healthcare costs, evolving lifestyles, innovations in food, and advancements in medical technology have also contributed to the rising demand for these products. Furthermore, the global fertility supplements market is expanding due to delayed pregnancies among women and ongoing declines in fertility rates. Interestingly, the COVID-19 pandemic had a favorable effect on the demand for fertility supplements, as research indicated that the virus could affect an individual's fertility. Additionally, a study published in January 2021, titled "The Potential Role of Zinc in the COVID-19 Disease Process and its Likely Impact on Reproduction," suggested that zinc supplements could mitigate damage to egg and sperm cells caused by the body's immune response to the coronavirus, thereby enhancing immunity. Such research findings have led to an increased demand for fertility supplements during the pandemic, positively influencing the market.

Key Market Drivers

Rising Fertility Concerns

In recent years, the global fertility supplements market has witnessed substantial growth, driven by an alarming increase in fertility concerns among individuals and couples. With factors like lifestyle changes, delayed family planning, and heightened stress levels affecting reproductive health, people are increasingly turning to fertility supplements as a potential solution. One of the significant factors driving the growth of the fertility supplements market is changing demographics. In many developed countries, there is a notable trend toward delayed childbearing. Couples are waiting until their late 20s or 30s to start their families. While this trend is often influenced by career goals and economic factors, it also comes with age-related fertility challenges. As women age, their fertility declines, making conception more difficult. This demographic shift has led to a surge in demand for fertility supplements among older couples looking to enhance their chances of successful conception. Modern lifestyles are marked by high levels of stress, sedentary routines, and poor dietary choices. These factors can have a negative impact on reproductive health. Stress, in particular, is known to disrupt hormonal balance and affect fertility. As awareness of these lifestyle-related fertility issues grows, individuals and couples are seeking ways to mitigate these effects. Fertility supplements, often formulated with vitamins, minerals, and herbal extracts, are perceived as a natural and accessible means to support reproductive health. Many couples are now waiting longer before embarking on parenthood due to various personal and professional considerations. However, this delay can lead to increased fertility concerns, especially for women over the age of 35. Fertility supplements are seen as a proactive measure to optimize reproductive health before attempting conception. As a result, these supplements have become an integral part of the family planning journey for many couples. Greater awareness about fertility issues and the potential benefits of fertility supplements has played a pivotal role in market growth. Information about fertility concerns and available solutions is now readily accessible through the internet and social media. This has empowered individuals and couples to take charge of their reproductive health and explore options like fertility supplements to address their specific needs. The rise of e-commerce has made fertility supplements more accessible and convenient to purchase. Consumers can research, compare, and order a wide range of products online, eliminating the need for physical visits to stores or pharmacies. This ease of access has contributed to the market's expansion, making fertility supplements available to a broader consumer base.

Delayed Childbearing

Delayed childbearing, a phenomenon increasingly prevalent in today's society, has far-reaching implications, not only for individuals and couples but also for the global fertility supplements market. As people around the world are choosing to start their families later in life, the demand for fertility supplements is on the rise. One of the most significant drivers of the growth in the fertility supplements market is the age-related fertility challenges that come with delayed childbearing. Many individuals and couples are waiting until their late 20s, 30s, or even 40s to have children. However, female fertility decreases with age, with a more pronounced decline after the age of 35. This reality has led to an increased awareness of the potential difficulties in conceiving later in life, prompting many to seek solutions to boost their chances of successful conception. As more people delay childbearing, there has been a parallel increase in awareness about reproductive health. Couples are taking proactive steps to understand and address their fertility concerns. They are seeking information about the factors that affect fertility and the various methods available to improve their chances of conceiving. Fertility supplements, formulated with vitamins, minerals, and herbal extracts, have emerged as a popular choice for individuals and couples looking to optimize their reproductive health. Fertility supplements are viewed as a supplemental support for fertility and reproductive well-being. They are often chosen for their potential to provide essential nutrients that may be lacking in one's diet or to address specific fertility-related issues. For individuals and couples who are delaying childbearing, these supplements can be an attractive option to bridge potential nutritional gaps and enhance their overall reproductive health. Manufacturers of fertility supplements have recognized the changing demographics and are tailoring their marketing strategies accordingly. They are targeting a specific demographic of older parents or individuals trying to conceive later in life. This targeted approach includes educational content, testimonials, and messaging that speaks to the unique concerns of this group, further driving demand for fertility supplements. Healthcare professionals are also playing a role in boosting the growth of the fertility supplements market. Many doctors and fertility specialists now recommend fertility supplements as part of preconception planning for individuals and couples, especially those who are starting their families later in life. These recommendations carry significant weight and instill confidence in the efficacy of these products.

Accessibility Through E-commerce

The global fertility supplements market is experiencing a significant transformation, largely driven by the rapid expansion of e-commerce. In recent years, accessibility through online platforms has played a pivotal role in facilitating the growth of this market. One of the most compelling reasons for the growth of the fertility supplements market through e-commerce is the unparalleled convenience it offers to consumers. In the past, individuals seeking fertility supplements would have to physically visit stores, pharmacies, or specialty shops. With e-commerce, they can now research, compare, and purchase a wide range of products from the comfort of their homes or on the go, simply by using a computer or mobile device. This convenience factor has significantly expanded the customer base. E-commerce transcends geographical boundaries, providing access to a global marketplace. Consumers are no longer limited to the selection available in their local stores. They can explore a vast array of fertility supplements from different manufacturers and regions, enabling them to find products that best suit their needs and preferences. This global reach has amplified competition and product diversity within the market. E-commerce platforms provide a wealth of information about fertility supplements. Consumers can access detailed product descriptions, ingredient lists, usage instructions, and customer reviews. This transparency empowers consumers to make informed choices, ensuring that they select products that align with their specific requirements. Moreover, the availability of customer reviews offers valuable insights into the efficacy and reliability of different supplements. Fertility is a deeply personal and sometimes sensitive topic. E-commerce offers a level of privacy and discretion that may not be attainable in physical stores. Individuals and couples can discreetly browse, research, and purchase fertility supplements without feeling self-conscious or exposed. This aspect of e-commerce has resonated with many consumers and has led to increased sales within the fertility supplements market. Many e-commerce platforms offer subscription services and auto-ship programs, allowing consumers to receive their chosen fertility supplements regularly without the hassle of placing orders repeatedly. This automated approach not only ensures a consistent supply of supplements but also fosters brand loyalty and repeat business. E-commerce fosters competition among sellers, which often results in competitive pricing. Consumers can compare prices across multiple platforms, enabling them to find the best deals and discounts. This price transparency has made fertility supplements more affordable and accessible to a wider audience.

Recommendations from Healthcare Professionals

The global fertility supplements market has experienced substantial growth in recent years, driven in part by an unlikely ally-healthcare professionals. As more individuals and couples grapple with fertility concerns, the endorsement and guidance of healthcare experts are playing a crucial role in propelling the market forward. Healthcare professionals, including doctors, obstetricians, gynecologists, and fertility specialists, are highly trusted sources of medical advice. When they recommend or endorse specific fertility supplements, it adds a layer of credibility and trustworthiness to these products. Patients often place great faith in the expertise and guidance of their healthcare providers, making them more likely to consider and use fertility supplements as part of their reproductive health journey. Fertility is a highly individualized concern, and healthcare professionals are well-equipped to provide personalized guidance to patients. When healthcare providers recommend fertility supplements, they can tailor their recommendations to the unique needs and circumstances of each patient. This personalized approach ensures that individuals receive the most appropriate and effective supplements for their specific fertility challenges. In some cases, fertility supplements are integrated into broader fertility treatment plans. Healthcare professionals may prescribe or recommend supplements alongside other interventions, such as assisted reproductive technologies or lifestyle modifications. This holistic approach reinforces the importance of fertility supplements in addressing specific fertility issues and encourages patient compliance. Healthcare professionals can monitor and evaluate the impact of fertility supplements on their patients' reproductive health. Through regular check-ups and diagnostic tests, they can assess the effectiveness of the supplements and make necessary adjustments to treatment plans. This ongoing monitoring reinforces patient confidence in the products and their healthcare providers. Fertility supplements often contain vitamins, minerals, and other nutrients that are essential for reproductive health. Healthcare professionals can identify nutritional gaps in their patients' diets through blood tests and assessments. When deficiencies are detected, they may recommend supplements as a means to bridge these gaps, promoting better overall health and fertility. Many fertility clinics and centers have established partnerships with supplement manufacturers. They offer patients access to high-quality fertility supplements that are specifically recommended by their healthcare providers. These collaborations provide patients with a seamless and trusted source for their supplement needs, further promoting the growth of the fertility supplements market. Healthcare professionals play a critical role in educating their patients about the benefits and risks of fertility supplements. They can provide guidance on proper usage, potential side effects, and interactions with other medications or treatments. This education empowers patients to make informed decisions about the supplements they choose to use.

Key Market Challenges

Regulatory Oversight

One of the most significant challenges facing the fertility supplements market is the lack of consistent and stringent regulatory oversight. Unlike pharmaceutical drugs, dietary supplements are subject to less rigorous scrutiny in many countries. This disparity raises concerns about the safety, efficacy, and quality of fertility supplements. Inconsistent regulations make it challenging for consumers to distinguish between reliable products and potentially harmful ones.

Lack of Scientific Evidence

While some fertility supplements claim to enhance reproductive health, the scientific evidence supporting their efficacy is often limited or inconclusive. The absence of robust clinical trials and long-term studies makes it difficult to ascertain the true benefits and risks of these products. This lack of scientific backing can undermine consumer confidence and trust in the industry.

Variability in Product Quality

The quality of fertility supplements can vary significantly from one brand to another. Subpar manufacturing processes, inadequate quality control, and questionable sourcing of ingredients can lead to inconsistent product quality. This variability raises concerns about the purity, potency, and safety of fertility supplements, making it challenging for consumers to make informed choices.

Misleading Marketing Claims

In the absence of strict regulations, some manufacturers engage in misleading or exaggerated marketing practices. Claims about the miraculous benefits of fertility supplements can create unrealistic expectations among consumers. Misleading marketing not only erodes trust but also poses potential health risks when individuals rely solely on supplements to address fertility concerns, instead of seeking proper medical advice and interventions.

Key Market Trends

Science-Backed Formulations

With growing scrutiny on the efficacy of fertility supplements, there is a clear trend toward science-backed formulations. Consumers are increasingly seeking products supported by rigorous clinical trials and research. Manufacturers are responding by investing in studies to provide evidence of the benefits of their supplements, instilling greater trust among consumers and healthcare professionals.

Plant-Based and Natural Ingredients

The preference for natural and plant-based ingredients is gaining traction in the fertility supplements market. Consumers are becoming more health-conscious and environmentally aware, leading to increased demand for supplements that rely on natural sources such as herbal extracts, antioxidants, and vitamins. This trend aligns with the broader movement toward cleaner and more sustainable living.

Male Fertility Supplements

Traditionally, fertility supplements have predominantly targeted women. However, there is a growing recognition of the importance of male reproductive health in fertility outcomes. As a result, the market is witnessing the emergence of male-specific fertility supplements designed to support sperm quality, motility, and overall reproductive wellness.

Diverse Product Formats

Fertility supplements are diversifying beyond traditional pill and capsule formats. Consumers are showing interest in alternative delivery methods, such as gummies, powders, and liquid formulations. These formats can offer convenience and variety, making it easier for individuals to incorporate supplements into their daily routines.

Segmental Insights

Ingredient Insights

Based on the category of Ingredient, the synthetic sector dominated in terms of revenue share in 2022. Notably, selenium, zinc, folic acid, vitamin C, vitamin B6, CoQ1, and Myo-Inositol played a significant role in driving overall growth because of heightened demand and their easy accessibility.

From 2023 to 2030, the natural segment is projected to experience substantial growth at a CAGR. This growth is expected to be propelled by the introduction of new products and technological advancements in the health and wellness industry. People are increasingly turning to plant-based products to maintain a healthy lifestyle and reduce the risk of side effects. There's a growing demand for plant extracts, especially herbs, in the pharmaceutical sector, driven by increased awareness of biologically sourced ingredients. However, this trend is likely to result in decreased availability of raw materials for natural food product manufacturers in the coming years.

Despite the rapid expansion of natural ingredients, a lack of scientific backing for claims has been a hindrance to this segment's growth. To address this, several governments have initiated studies to promote the adoption of natural products, which is expected to boost demand for such products in the foreseeable future.

End-use Insights

In 2022, the women's category held the largest market share. According to data from the Centers for Disease Control and Prevention, approximately 19% of women aged 15-49 with no prior childbirth history face challenges related to infertility. Notably, the highest prevalence of fertility issues was observed among married women aged 40 to 44, followed by those aged 35 to 39. Government and non-profit organizations have launched initiatives aimed at providing guidance and medical support, leading to increased awareness and creating opportunities for manufacturers in this market.

The men's segment is expected to witness significant growth at a CAGR during the forecast period. Some of the most common factors contributing to infertility in men include hypogonadism, immune system-related issues, varicocele, systemic diseases, sexual factors, undescended testicles, and urogenital infections. Notably, male factors are responsible for approximately 20% of all infertility cases and contribute to another 30% to 40%. According to a research paper published in the National Library of Medicine in 2022, male factors play a significant role in approximately 50% of all infertility cases, which is expected to drive demand for products in this segment in the coming years.

Regional Insights

In 2022, North America dominated the market in terms of revenue share. According to the December 2021 update from the Centers for Disease Control and Prevention (CDC), 13.1% of women aged 15 to 49 in the United States experienced fertility issues, while 14.1% of married women in the same age group faced fertility challenges. Additionally, 6% of married women were identified as infertile, which drove the demand for products in this region. Furthermore, in Canada, the market is expected to experience rapid growth due to increased efforts by the government and non-profit organizations like Fertility Matters Canada to raise awareness about fertility treatments and medications. The rising rates of obesity and sexually transmitted infections in Canada are also contributing to this growth.

Looking ahead, the Asia Pacific region is poised for substantial growth with a significant CAGR expected from 2023 to 2030. This region presents attractive opportunities for leading companies in the fertility supplement market, thanks to improved access to healthcare facilities and increased investment in research and healthcare sectors. The growing awareness of nutritional enrichment in countries like India and China is anticipated to be a key driver of regional growth. Additionally, regulatory support encouraging investment in the retail market in nations such as India, China, Indonesia, and Malaysia is expected to enhance consumer accessibility, thus facilitating market expansion in the region.

Key Market Players

Fairhaven Health LLC

Coastal Sciences

LENUS Pharma GesmbH

Orthomol Pharmazeutische Vertriebs GmbH

Exeltis USA Inc

PrepMe LLC

Bionova Inc

TTK Healthcare Ltd

Vitabiotics Ltd

VH Nutrition LLC

Report Scope:

In this report, the Global Fertility Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fertility Supplements Market, By Ingredient:

• Natural
• Synthetic/ Blend of Natural & Synthetic

Fertility Supplements Market, By Product:

• Capsules
• Tablets
• Soft Gels
• Powders
• Liquids

Fertility Supplements Market, By End-use:

• Men
• Women

Fertility Supplements Market, By Distribution Channel:

• OTC
• Prescribed

Fertility Supplements Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Fertility Supplements Market.

Available Customizations:

• Global Fertility Supplements market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Fertility Supplements Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Ingredient (Natural, Synthetic/ Blend of Natural & Synthetic)
  • 5.2.2. By Product (Capsules, Tablets, Soft Gels, Powders, Liquids)
  • 5.2.3. By End-use (Men, Women)
  • 5.2.4. By Distribution Channel (OTC, Prescribed)
  • 5.2.5. By Region
  • 5.2.6. By Company (2022)
• 5.3. Product Market Map
  • 5.3.1. By Ingredient
  • 5.3.2. By Product
  • 5.3.3. By End-use
  • 5.3.4. By Distribution Channel
  • 5.3.5. By Region

6. North America Fertility Supplements Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Ingredient (Natural, Synthetic/ Blend of Natural & Synthetic)
  • 6.2.2. By Product (Capsules, Tablets, Soft Gels, Powders, Liquids)
  • 6.2.3. By End-use (Men, Women)
  • 6.2.4. By Distribution Channel (OTC, Prescribed)
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Fertility Supplements Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Ingredient
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By End-use
      • 6.3.1.2.4. By Distribution Channel
  • 6.3.2. Canada Fertility Supplements Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Ingredient
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By End-use
      • 6.3.2.2.4. By Distribution Channel
  • 6.3.3. Mexico Fertility Supplements Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Ingredient
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By End-use
      • 6.3.3.2.4. By Distribution Channel

7. Europe Fertility Supplements Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Ingredient (Natural, Synthetic/ Blend of Natural & Synthetic)
  • 7.2.2. By Product (Capsules, Tablets, Soft Gels, Powders, Liquids)
  • 7.2.3. By End-use (Men, Women)
  • 7.2.4. By Distribution Channel (OTC, Prescribed)
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Fertility Supplements Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Ingredient
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By End-use
      • 7.3.1.2.4. By Distribution Channel
  • 7.3.2. United Kingdom Fertility Supplements Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Ingredient
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By End-use
      • 7.3.2.2.4. By Distribution Channel
  • 7.3.3. France Fertility Supplements Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Ingredient
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By End-use
      • 7.3.3.2.4. By Distribution Channel
  • 7.3.4. Italy Fertility Supplements Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Ingredient
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By End-use
      • 7.3.4.2.4. By Distribution Channel
  • 7.3.5. Spain Fertility Supplements Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Ingredient
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By End-use
      • 7.3.5.2.4. By Distribution Channel

8. Asia-Pacific Fertility Supplements Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Ingredient (Natural, Synthetic/ Blend of Natural & Synthetic)
  • 8.2.2. By Product (Capsules, Tablets, Soft Gels, Powders, Liquids)
  • 8.2.3. By End-use (Men, Women)
  • 8.2.4. By Distribution Channel (OTC, Prescribed)
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Fertility Supplements Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Ingredient
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By End-use
      • 8.3.1.2.4. By Distribution Channel
  • 8.3.2. Japan Fertility Supplements Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Ingredient
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By End-use
      • 8.3.2.2.4. By Distribution Channel
  • 8.3.3. India Fertility Supplements Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Ingredient
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By End-use
      • 8.3.3.2.4. By Distribution Channel
  • 8.3.4. Australia Fertility Supplements Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Ingredient
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By End-use
      • 8.3.4.2.4. By Distribution Channel
  • 8.3.5. South Korea Fertility Supplements Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Ingredient
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By End-use
      • 8.3.5.2.4. By Distribution Channel

9. South America Fertility Supplements Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Ingredient (Natural, Synthetic/ Blend of Natural & Synthetic)
  • 9.2.2. By Product (Capsules, Tablets, Soft Gels, Powders, Liquids)
  • 9.2.3. By End-use (Men, Women)
  • 9.2.4. By Distribution Channel (OTC, Prescribed)
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Fertility Supplements Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Ingredient
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By End-use
      • 9.3.1.2.4. By Distribution Channel
  • 9.3.2. Argentina Fertility Supplements Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Ingredient
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By End-use
      • 9.3.2.2.4. By Distribution Channel
  • 9.3.3. Colombia Fertility Supplements Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Ingredient
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By End-use
      • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Fertility Supplements Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Ingredient (Natural, Synthetic/ Blend of Natural & Synthetic)
  • 10.2.2. By Product (Capsules, Tablets, Soft Gels, Powders, Liquids)
  • 10.2.3. By End-use (Men, Women)
  • 10.2.4. By Distribution Channel (OTC, Prescribed)
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Fertility Supplements Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Ingredient
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By End-use
      • 10.3.1.2.4. By Distribution Channel
  • 10.3.2. Saudi Arabia Fertility Supplements Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Ingredient
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By End-use
      • 10.3.2.2.4. By Distribution Channel
  • 10.3.3. UAE Fertility Supplements Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Ingredient
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By End-use
      • 10.3.3.2.4. By Distribution Channel
  • 10.3.4. Kuwait Fertility Supplements Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Ingredient
      • 10.3.4.2.2. By Product
      • 10.3.4.2.3. By End-use
      • 10.3.4.2.4. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Business Overview
• 14.2. Product Offerings
• 14.3. Recent Developments
• 14.4. Financials (As Reported)
• 14.5. Key Personnel
• 14.6. SWOT Analysis
  • 14.6.1. Fairhaven Health LLC
  • 14.6.2. Coastal Sciences
  • 14.6.3. LENUS Pharma GesmbH
  • 14.6.4. Orthomol Pharmazeutische Vertriebs GmbH
  • 14.6.5. Exeltis USA Inc
  • 14.6.6. PrepMe LLC
  • 14.6.7. Bionova Inc
  • 14.6.8. TTK Healthcare Ltd
  • 14.6.9. Vitabiotics Ltd
  • 14.6.10. VH Nutrition LLC

15. Strategic Recommendations

16. About Us & Disclaimer